Quique Montagud

No te tiene que gustar maduro para criticar lo que ha hecho EE.UU.

Join GlomCon in its Kidney Transplantation Series this Sunday Pancreas Transplantation by Dr. Pedro Ventura Aguiar ID: 817 4374 4653 Passcode 202122 sign up 👉 bit.ly/signup-glomcon #GlomCon

🎉Congratulations to Dra. Carolt Arana who just received the @ERAkidney National Grant during #Senefro25 Oviedo Congress👏

Ya se puede votar a la JD de la SEN. Mira tu mail enviado por la SEN y sigue los pasos. Si votas, decides. @lasenestuya @piermartinzal @juanmbuadesfust @MariaIzqOrt @egonzalezpa2024 @IgnacioRevuelt5 @JoseIbeas1 @josedelaflor4

Nuestra sociedad no puede quedar al margen de la IA. @josedelaflor4 @JoseIbeas1 @Cr_Galeano

⏳Time to refine induction therapy in SPKT? 💊Basiliximab vs thymo in low immunological risk patients: ➡️Similar patient and graft survival🎯 ➡️Similar rejection rate⚡️ ⬇️CMV infections📉 ⬇️BKV infection📉 frontierspartnerships.org/journals/trans… @PVentura_Aguiar

KDIGO is excited to share the publication of the 2025 Clinical Practice Guideline for the Management of IgA Nephropathy (#IgAN) and IgA Vasculitis (#IgAV), along with the Executive Summary in @Kidney_Int. Read the Guideline in KI: kdigo.co/KDIGO-IgAN-IgA… Download the Executive Summary: kdigo.co/IgAN-IgAV-Guid… Read the News Release: kdigo.co/KDIGO-IgAN-IgA… Co-chaired by Dr. Jürgen Floege (DE) and @BradRovin, this update to the 2021 KDIGO Glomerular Diseases Guideline on IgAN incorporates evidence through August 2024. Given the rapid pace of discovery, KDIGO will continue to update the guideline regularly so clinicians and patients have access to the latest science and recommendations. “This guideline represents a fundamental shift in how we approach IgA nephropathy,” said Dr. Floege. “For the first time, we can target both the immune mechanisms driving IgA injury and the kidney’s maladaptive responses. This dual strategy offers a roadmap to slow progression and extend kidney survival in ways not possible just a few years ago.” “The science is moving faster than ever, and the treatment landscape has changed dramatically,” said Dr. Rovin. “With therapies like targeted-release budesonide, sparsentan, and SGLT2 inhibitors, we can intervene earlier and tailor care. We are moving from a single approach to a toolkit of therapies that can truly change outcomes for people around the world." Download the Guideline: kdigo.co/KDIGO-IgAN-IgA…

👩‍⚕️ La fotoaféresis extracorpórea en 13 👥con nefropatía BK refractaria. ✅ Viremia ⤵️ hasta 99.9% en 18 m ✅Buen perfil de seguridad ✅Solo 1 rechazo pese a bajar inmunosupresión @hospitalclinic doi.org/10.1093/ckj/sf…

EVNP💈 for enhancing tubuloid-base therapies in kidney regenerative medicine: ⚡️Enhanced delivery vs in situ injection 🫧Successful integration 🧬Fully developed tubular structures Check out our recent work! @hospitalclinic @jmcampis @FritzDiekmann frontierspartnerships.org/journals/trans…

Nuestra candidatura apuesta por recuperar áreas propias propias de la especialidad. ⁦@GEMAVsociedad⁩ ⁦@NefrologiaHRyC⁩ ⁦@Nefro12Octubre⁩ ⁦@NefroHUVmaca⁩ ⁦@SVNefro⁩ ⁦@SOMANEorg⁩ ⁦@nefrosan⁩ ⁦@sengndi⁩

🎂 Avui estem d’aniversari: fa 6⃣0⃣ anys que al #CLÍNIC s’hi va fer el primer trasplantament de ronyó de l’Estat espanyol! 🩺 Sabies que des de 1965 hem fet 5⃣.8⃣0⃣6⃣ trasplantaments de ronyó i seguim líders? ➕Info 👉 clinicbarcelona.org/ca/noticies/60…

Estem d’aniversari 🫶🏼🎂🎂🎂🎂🎂 El Clínic ha fet 5.806 trasplantaments de ronyó en 60 anys beteve.cat/societat/hospi…

El Dr. Emilio González Parra nos presenta su candidatura para la S.E.N. 2026 - 2029 Tú haces la S.E.N. Forma parte del futuro. Participa. Decide. Impúlsala. #Nefrología

Proud of our Kidney Transplantation and LENIT team from @hospitalclinic at #ESOT2025 in London. Advancing knowledge, sharing experience, and working together to improve transplant care. #KidneyTransplant #Transplantation #ESOT

📢New tools for diagnosing pancreas rejection?⚡️ In SPKT, Trugraf demonstrated: ⬆️correlation with TCMR 📈83% NPV, 85% Specificity (higher with per cause biopsies) ⬆️ correlation with graft immune transcripts. @PVentura_Aguiar presents promising results at #IPITA2025

🎯Basiliximab vs Thymo in low immune risk SPKT: ✅Similar recipient survival ✅Similar graft survival ✅No increased risk of graft rejection 📣Lower risk of CMV and BK infection Sharing new insights in pancreas induction therapy at #IPITA2025! @PVentura_Aguiar

Experiencia del @hospitalclinic 👉 Implementación de la técnica interna (in-house) de determinación del ADN libre del donante en la actividad clínica diaria revistanefrologia.com/es-implementac… @dianarodespi @AMolina_Anduja @PVentura_Aguiar @torreandfriends @jbroseta @elenc93

Avui fa un any que ens va deixar el Dr. Manel Vera. Amic i nefròleg de l’@hospitalclinic, vas deixar un buit impossible d’omplir. La família, amics i companys et trobem moltíssim a faltar. Descansa en pau, Manel.

Los que no sois de Valencia igual os sorprende, pero los que somos sabemos perfectamente que esto va a más. Va a más porque sigue contando bulos y se ríe de las víctimas. Orihuela está en la otra punta y así lo reciben. Si va a Paiporta se lo comen.

👉 Si quieres saber más, consulta el artículo completo aquí: doi.org/10.1016/j.nefr… @dianarodespi @AMolina_Andujar @QuimonMar @AranaCarolt @torreandfriends @PVentura_Aguiar @jbroseta @FritzDiekmann @CucchiariD